Amol Akhade: Want to Raise a Critical Point on a Published Clinical Trial?

Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics, shared a post on X:

“Want to raise a critical point on a published clinical trial?

What actually works to reach right people and spark discussion?

1. Letter to the Editor – 95% desk rejection (especially if it’s a sponsored trial…)
2. Post on X or LinkedIn – wider audience, real engagement
3. Try both – submit letter if rejected, post it as an open letter on X .
4. Forget it – read, think, move on- repeat

What’s your go-to strategy? Vote and discuss.”

According to the responses:

• 11.2% of participants preferred raising their critical point by writing a formal Letter to the Editor.
• 37.4% chose to share their perspective publicly through a post on platforms like X or LinkedIn.
• 35.5% believed in combining both approaches—submitting a Letter to the Editor while also posting on social media to reach a wider audience.
• 15.9% indicated they would simply read, reflect on the issue, and ultimately move on without taking further action.

More posts featuring Amol Akhade.